Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Other Working Capital Changes (2015 - 2026)

Cellectis (CLLS) posted quarterly Other Working Capital Changes of $965000.0 for Q1 2026, up 14.47% year-over-year from $843000.0 in Q1 2025, and up 753.98% quarter-over-quarter from $113000.0 in Q4 2025.

Analysis

Cellectis (CLLS) Other Working Capital Changes (2015 - 2026) Analysis & Trends

Cellectis' Other Working Capital Changes history runs 13 years deep, the most recent figure standing at $965000.0 for Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 14.47% year-over-year to $965000.0; the TTM figure through Mar 2026 stood at $965000.0 (up 14.47% YoY), while the FY2025 annual figure was $1.2 million, up 162.35% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at $965000.0, up from $113000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $9.5 million in Q1 2025, with the low at -$130.1 million in Q2 2025.
  • The 5-year median for Other Working Capital Changes is -$216500.0 (2022), against an average of -$25.0 million.
  • The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes soared 183.97% in 2023, then slumped 268.8% in 2024.
  • Cellectis' Other Working Capital Changes stood at $237000.0 in 2022, then jumped by 183.97% to $673000.0 in 2023, then plunged by 268.8% to -$1.1 million in 2024, then soared by 109.95% to $113000.0 in 2025, then jumped by 753.98% to $965000.0 in 2026.
  • Business Quant data shows CLLS's Other Working Capital Changes at $965000.0 in Q1 2026, $113000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Cellectis 321.90 Mn 155.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Jun 30, 2026 1.10 Mn
Mar 31, 2026 611,000.00
Mar 31, 2026 611,000.00
Dec 31, 2025 -1.37 Mn
Dec 31, 2025 -1.37 Mn
Sep 30, 2025 -16.74 Mn
Sep 30, 2025 -16.74 Mn
Jun 30, 2025 -12.27 Mn
Jun 30, 2025 -12.27 Mn
Mar 31, 2025 -11.22 Mn
Mar 31, 2025 -11.22 Mn
Dec 31, 2024 5.26 Mn
Dec 31, 2024 5.26 Mn
Sep 30, 2024 100.52 Mn
Sep 30, 2024 100.52 Mn
Jun 30, 2024 -43.22 Mn
Jun 30, 2024 -43.22 Mn
Mar 31, 2024 -8.89 Mn
Mar 31, 2024 -8.89 Mn